Cargando…
Pioglitazone and the Risk of Bladder Cancer: A Meta-Analysis
People with type 2 diabetes are at increased risk of bladder cancer. Pioglitazone is said to increase it further, although published evidence is mixed. We conducted a meta-analysis to determine if any link between the use of pioglitazone and an increased risk of bladder cancer can be found. A compre...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Healthcare
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5544610/ https://www.ncbi.nlm.nih.gov/pubmed/28623552 http://dx.doi.org/10.1007/s13300-017-0273-4 |